Gyre TherapeuticsGYRE
13F holders, Q4 2024 (December 31)40holders +3
4new positions
2sold out
$12.10avg. 13F price*
At the end of Q4 2024, 40 institutions reported holding Gyre Therapeutics Inc. (GYRE) in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($6.4M), Vanguard Group Inc. ($3.9M) and Geode Capital Management, LLC ($3.7M).
- Company
- Gyre Therapeutics Inc.
- CUSIP
- 403783103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $15K |
| Exits | 2 | $88 |
All 13F filers, Q3 2024 → Q4 2024: 118,115 shares bought and 42,386 shares sold, net +75,729 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| BlackRock, Inc. | 0.00% | Add +3.4% | 531,680 | $6.4M |
| Vanguard Group Inc. | 0.00% | Reduce -5.2% | 322,464 | $3.9M |
| Geode Capital Management, LLC | 0.00% | Add +0.1% | 304,098 | $3.7M |
| State Street Corp. | 0.00% | Add +21.2% | 126,647 | $1.5M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +0.8% | 114,566 | $1.4M |
| Northern Trust Corp. | 0.00% | Add +9.1% | 103,382 | $1.3M |
| SBI Securities Co., Ltd. | 0.04% | — | 101,239 | $1.2M |
| UBS Group AG | 0.00% | Add +1467.0% | 57,084 | $691K |
| Goldman Sachs Group Inc. | 0.00% | Add +40.4% | 26,386 | $319K |
| Morgan Stanley | 0.00% | Reduce -16.4% | 15,241 | $184K |
| Bank of New York Mellon Corp | 0.00% | Add +11.1% | 13,896 | $168K |
| Barclays PLC | 0.00% | Add +13.5% | 10,543 | $128K |
| Rhumbline Advisers | 0.00% | Add +0.1% | 10,432 | $126K |
| Advantage Alpha Capital Partners LP | 0.03% | Reduce -66.7% | 8,873 | $107K |
| Bank of America Corp. | 0.00% | Add +40.4% | 6,937 | $84K |
| Citigroup Inc. | 0.00% | Add +6.4% | 5,399 | $65K |
| Wells Fargo & Company | 0.00% | Add +29.4% | 4,016 | $49K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +3.9% | 4,013 | $49K |
| Corebridge Financial, Inc. | 0.00% | Reduce -7.0% | 3,468 | $42K |
| JPMorgan Chase & Co. | 0.00% | Add +7.8% | 3,269 | $40K |
| New York State Common Retirement Fund | 0.00% | No change | 2,700 | $33K |
| Belvedere Trading LLC | 0.00% | Reduce -2.1% | 2,461 | $30K |
| BNP Paribas Financial Markets | 0.00% | Reduce -28.4% | 1,394 | $17K |
| FMR LLC | 0.00% | Reduce -66.4% | 1,256 | $15K |
| Picton Mahoney Asset Management | 0.00% | New | 1,120 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.7% | 852 | $10K |
| Royal Bank of Canada | 0.00% | Reduce -16.0% | 810 | $10K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 683 | $8K |
| Legal & General Group Plc | 0.00% | No change | 603 | $7K |
| Activest Wealth Management | 0.00% | No change | 533 | $6K |
| California State Teachers Retirement System | 0.00% | No change | 505 | $6K |
| Amalgamated Bank | 0.00% | No change | 241 | $3K |
| Sterling Capital Management LLC | 0.00% | Add +928.6% | 216 | $3K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 84 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 75 | $908 |
| Osaic Holdings, Inc. | 0.00% | Reduce -90.7% | 41 | $496 |
| GAMMA Investing LLC | 0.00% | New | 12 | $145 |
| IFP Advisors, Inc | 0.00% | New | 2 | $24 |
| Cwm, LLC | 0.00% | Reduce -50.0% | 15 | $0 |
| Covestor Ltd | 0.00% | Add +16.7% | 7 | $0 |
"% of holder's portfolio" is GYRE's weight in each manager's 13F, not the share of Gyre Therapeutics Inc. the manager owns.